ZIOPHARM Oncology EV to EBIT (TTM)
View 4,000+ financial data types
ZIOPHARM Oncology EV to EBIT (TTM) Chart
ZIOPHARM Oncology Historical EV to EBIT (TTM) DataPro Export Data Date Range:
|Data for this Date Range|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About EV / EBIT
Enterprise value of a company divided by its Earnings Before Interest Taxes (TTM).
EV/EBIT answers the question "What is a company being valued per each dollar of EBIT?" A high (low) EV/EBIT mean the company is potentially overvalued (undervalued).
EV/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.
Other similar metrics include :
EV/EBITDA : How much is each dollar of EBITDA worth to investors?
EV/Revenues : Or each dollar of Revenues?
EV/Free Cash Flow : Or each dollar of FCF?
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
ZIOP EV to EBIT (TTM) Benchmarks
|Intrexon Corp||Go Pro|
|Spectrum Pharmaceuticals||Go Pro|
Zacks 03/07 08:37 ET
Yahoo 03/07 06:45 ET
Street Insider 03/04 10:22 ET
Street Insider 03/03 16:41 ET
GlobeNewswire 03/03 16:37 ET
Yahoo 03/03 16:30 ET
The Street 02/26 02:33 ET
The Street 02/24 05:39 ET
Yahoo 02/18 18:32 ET